Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human factor VIII prophylaxis in previously treated hemophilia A patients
CTR20190747Phase 3Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Apr 2019; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20190747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190747.